MedTrace Logo

Impedancemetry in Patients Monitored for Pulmonary Hypertension

NCT03673774 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2023-07-12

No results posted yet for this study

Summary

Monocentric cohort study, prospective, evaluating the variability of cardiac output measurement by resting and stress impedancemetry as a prognostic factor for Pulmonary Hypertension

Conditions

  • Pulmonary Hypertension

Interventions

DEVICE

cardiac impedancemetry

The cardiac output is measured by impedance measurement at rest and during the walking test.

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Elise Noel-Savina, MD · CHU of Toulouse

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-23
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03673774 on ClinicalTrials.gov